276 related articles for article (PubMed ID: 37236766)
1. The role of oxylipins in NSAID-exacerbated respiratory disease (N-ERD).
Cousins K; Chen CC; Sehanobish E; Jerschow E
Adv Pharmacol; 2023; 97():423-444. PubMed ID: 37236766
[TBL] [Abstract][Full Text] [Related]
2. Lipid Mediators in Aspirin-Exacerbated Respiratory Disease.
Parker AR; Ayars AG; Altman MC; Henderson WR
Immunol Allergy Clin North Am; 2016 Nov; 36(4):749-763. PubMed ID: 27712768
[TBL] [Abstract][Full Text] [Related]
3. Induced sputum eicosanoids during aspirin bronchial challenge of asthmatic patients with aspirin hypersensitivity.
Mastalerz L; Celejewska-Wójcik N; Wójcik K; Gielicz A; Januszek R; Cholewa A; Stręk P; Sanak M
Allergy; 2014 Nov; 69(11):1550-9. PubMed ID: 25123806
[TBL] [Abstract][Full Text] [Related]
4. Sputum biomarkers during aspirin desensitization in nonsteroidal anti-inflammatory drugs exacerbated respiratory disease.
Tyrak KE; Kupryś-Lipińska I; Czarnobilska E; Jakieła B; Pajdzik K; Ćmiel A; Plutecka H; Koziej M; Gawrońska A; Konduracka E; Kuna P; Sanak M; Mastalerz L
Respir Med; 2019 Jun; 152():51-59. PubMed ID: 31128610
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneity of lower airway inflammation in patients with NSAID-exacerbated respiratory disease.
Jakiela B; Soja J; Sladek K; Przybyszowski M; Plutecka H; Gielicz A; Rebane A; Bochenek G
J Allergy Clin Immunol; 2021 Apr; 147(4):1269-1280. PubMed ID: 32810516
[TBL] [Abstract][Full Text] [Related]
6. Aspirin Actions in Treatment of NSAID-Exacerbated Respiratory Disease.
Sehanobish E; Asad M; Barbi M; Porcelli SA; Jerschow E
Front Immunol; 2021; 12():695815. PubMed ID: 34305932
[TBL] [Abstract][Full Text] [Related]
7. The Role of Omalizumab in NSAID-Exacerbated Respiratory Disease: A Narrative Review.
Taniguchi M; Heffler E; Olze H; White A; Côrte-Real J; Olsson P; Lazarewicz S
J Allergy Clin Immunol Pract; 2022 Oct; 10(10):2570-2578. PubMed ID: 35764285
[TBL] [Abstract][Full Text] [Related]
8. Aspirin exacerbated respiratory disease: Current topics and trends.
Rodríguez-Jiménez JC; Moreno-Paz FJ; Terán LM; Guaní-Guerra E
Respir Med; 2018 Feb; 135():62-75. PubMed ID: 29414455
[TBL] [Abstract][Full Text] [Related]
9. Clinical benefits of aspirin desensitization in patients with nonsteroidal anti-inflammatory drug exacerbated respiratory disease are not related to urinary eicosanoid release and are accompanied with decreased urine creatinine.
Makowska JS; Olszewska-Ziąber A; Bieńkiewicz B; Lewandowska-Polak A; Kurowski M; Woźniakowski B; Rotkiewicz A; Kowalski ML
Allergy Asthma Proc; 2016 May; 37(3):216-24. PubMed ID: 27178890
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin D₂: a dominant mediator of aspirin-exacerbated respiratory disease.
Cahill KN; Bensko JC; Boyce JA; Laidlaw TM
J Allergy Clin Immunol; 2015 Jan; 135(1):245-52. PubMed ID: 25218285
[TBL] [Abstract][Full Text] [Related]
11. Safety risks for patients with aspirin-exacerbated respiratory disease after acute exposure to selective nonsteroidal anti-inflammatory drugs and COX-2 inhibitors: Meta-analysis of controlled clinical trials.
Morales DR; Lipworth BJ; Guthrie B; Jackson C; Donnan PT; Santiago VH
J Allergy Clin Immunol; 2014 Jul; 134(1):40-5. PubMed ID: 24388008
[TBL] [Abstract][Full Text] [Related]
12. Quantitative profiling of inflammatory and pro-resolving lipid mediators in human adolescents and mouse plasma using UHPLC-MS/MS.
Hartling I; Cremonesi A; Osuna E; Lou PH; Lucchinetti E; Zaugg M; Hersberger M
Clin Chem Lab Med; 2021 Oct; 59(11):1811-1823. PubMed ID: 34243224
[TBL] [Abstract][Full Text] [Related]
13. Adverse respiratory reactions to aspirin and nonsteroidal anti-inflammatory drugs.
Simon RA
Curr Allergy Asthma Rep; 2004 Jan; 4(1):17-24. PubMed ID: 14680616
[TBL] [Abstract][Full Text] [Related]
14. NSAID-ERD Syndrome: the New Hope from Prevention, Early Diagnosis, and New Therapeutic Targets.
Laidlaw TM; Levy JM
Curr Allergy Asthma Rep; 2020 Mar; 20(4):10. PubMed ID: 32172365
[TBL] [Abstract][Full Text] [Related]
15. Inheritance of NSAID-Exacerbated Respiratory Disease.
Suikkila A; Lyly A; Hafrén L; Saarinen R; Klockars T
Otolaryngol Head Neck Surg; 2023 Mar; 168(3):540-543. PubMed ID: 35639475
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of Benefit with Aspirin Therapy in Aspirin-Exacerbated Respiratory Disease.
Hill J; Burnett T; Katial R
Immunol Allergy Clin North Am; 2016 Nov; 36(4):735-747. PubMed ID: 27712767
[TBL] [Abstract][Full Text] [Related]
17. Biochemical pathogenesis of aspirin exacerbated respiratory disease (AERD).
Narayanankutty A; Reséndiz-Hernández JM; Falfán-Valencia R; Teran LM
Clin Biochem; 2013 May; 46(7-8):566-78. PubMed ID: 23246457
[TBL] [Abstract][Full Text] [Related]
18. Omalizumab-Induced Aspirin Tolerance in Nonsteroidal Anti-Inflammatory Drug-Exacerbated Respiratory Disease Patients Is Independent of Atopic Sensitization.
Quint T; Dahm V; Ramazanova D; Arnoldner MA; Kurz H; Janik S; Brunner PM; Knerer-Schally B; Weninger W; Griss J; Ristl R; Schneider S; Bangert C
J Allergy Clin Immunol Pract; 2022 Feb; 10(2):506-516.e6. PubMed ID: 34678497
[TBL] [Abstract][Full Text] [Related]
19. Aspirin desensitization following endoscopic sinus surgery is effective in patients with nonsteroidal antiinflammatory drug exacerbated respiratory disease.
Aydin Ö; Atmiş EÖ; Anadolu Y; Yorulmaz İ; Çelik GE
J Asthma; 2023 Jun; 60(6):1131-1140. PubMed ID: 36218308
[TBL] [Abstract][Full Text] [Related]
20. Unique Effect of Aspirin Therapy on Biomarkers in Aspirin-exacerbated Respiratory Disease. A Prospective Trial.
Cahill KN; Cui J; Kothari P; Murphy K; Raby BA; Singer J; Israel E; Boyce JA; Laidlaw TM
Am J Respir Crit Care Med; 2019 Sep; 200(6):704-711. PubMed ID: 30978291
[No Abstract] [Full Text] [Related]
[Next] [New Search]
